NetraMark Holdings Inc. (the "Company" or "NetraMark") , an artificial intelligence (AI) company that is transforming ...

A new study reveals a shocking jump in “biological age” among Gen-X, Millennials, and Gen-Z—and it might explain the rise in early-onset cancers.

The concept of biological age, distinct from chronological age, is gaining public traction, though often misinterpreted.

Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the definition of HF and its antecedent stages have limited research, global ...

A risk model that combines a mammographic artificial intelligence (AI) risk score with polygenic and clinical risk scores ...

Cancer is one of the leading causes of death and disability, affecting millions of working-age adults and their families each ...

For a child diagnosed with neuroblastoma—the most common infant cancer, occurring when early nerve cells grow out of ...

We look at power, speed, calories, recovery, fuelling and more to compare a Tour de France rider's efforts to those of an ...

From AI-assisted high-complexity cardiovascular interventions—where digital algorithms pre-simulate intricate surgical ...

PS, designed entirely by artificial intelligence, passed its first human safety trial at Cambridge — triggering ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its clinical development programs for the treatment of children with achondroplasia will be shared in an oral presentation ...

Natera, Inc. , a global leader in cell-free DNA and precision medicine, today announced that the National Comprehensive Cancer Network® (NCCN®) has updated its Clinical Practice Guidelines in Oncology ...